{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:12:01Z","timestamp":1790053921023,"version":"4.0.1"},"reference-count":148,"publisher":"Baishideng Publishing Group Inc.","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3748\/wjg.v20.i30.10383","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T01:46:20Z","timestamp":1408326380000},"page":"10383","source":"Crossref","is-referenced-by-count":76,"title":["Hepatitis B vaccine by intradermal route in non responder patients: An update"],"prefix":"10.3748","volume":"20","author":[{"given":"Martina","family":"Filippelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxj009"},{"key":"ref2","unstructured":"Sylvan S. [WHO spearheads global initiative to eradicate hepatitis B]. Lakartidningen 2000;97:3738-3740."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.056"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00031-6"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00410-2"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyi206"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013734525348"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.07.029"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310134"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.07.013"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2006.01.004"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3180320654"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.023"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7423.1075"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90006-X"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nri1310"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116873"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00653-6"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Flacher V, Bouschbacher M, Verron&egrave;se E, Massacrier C, Sisirak V, Berthier-Vergnes O, de Saint-Vis B, Caux C, Dezutter-Dambuyant C, Lebecque S. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J Immunol 2006;177:7959-7967.","DOI":"10.4049\/jimmunol.177.11.7959"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.7.8.1201"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.03.095"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N, Caux C, A&iuml;t-Yahia S, Vicari A, Kaiserlian D. Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006;24:191-201.","DOI":"10.1016\/j.immuni.2006.01.005"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, Lew AM, Shortman K, Heath WR, Carbone FR. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006;25:153-162.","DOI":"10.1016\/j.immuni.2006.04.017"},{"key":"ref24","unstructured":"Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000;78:693-698."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00290-09"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Icardi G, Orsi A, Ceravolo A, Ansaldi F. Current evidence on intradermal influenza vaccines administered by Soluvia&trade; licensed micro injection system. Hum Vaccin Immunother 2012;8:67-75.","DOI":"10.4161\/hv.8.1.18419"},{"key":"ref27","unstructured":"Comparative trial of live attenuated measles vaccine in Hong Kong by intramuscular and intradermal injection. Bull World Health Organ 1967;36:375-384."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1997.0103"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)90187"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Nicholson KG, Prestage H, Cole PJ, Turner GS, Bauer SP. Multisite intradermal antirabies vaccination. Immune responses in man and protection of rabbits against death from street virus by postexposure administration of human diploid-cell-strain rabies vaccine. Lancet 1981;2:915-918.","DOI":"10.1016\/S0140-6736(81)91402-1"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92367-0"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90800-0"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.262.18.2567"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(58)90256-3"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00293-4"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00028-2"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1211"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1378\/chest.106.5.1463"},{"key":"ref39","unstructured":"Rabies vaccines. WHO position paper. Wkly Epidemiol Rec 2007;82:425-435."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.033"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007;25:8833-8842.","DOI":"10.1016\/j.vaccine.2007.10.020"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.01.043"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1080\/00365520701733806"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/adc.65.5.527"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i6.838"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Kim YC, Prausnitz MR. Enabling skin vaccination using new delivery technologies. Drug Deliv Transl Res 2011;1:7-12.","DOI":"10.1007\/s13346-010-0005-z"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(86)80051-4"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5812\/kowsar.1735143X.715"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Niiya T, Akbar SM, Yoshida O, Miyake T, Matsuura B, Murakami H, Abe M, Hiasa Y, Onji M. Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice. J Nutr 2007;137:671-675.","DOI":"10.1093\/jn\/137.3.671"},{"key":"ref50","unstructured":"Shakhgil'dian IV, Khukhlovich PA, Savin EA, Kuzin SN, Anan&rsquo;ev VA, Sergeeva NA, Khasanova VA, Shostka GD, Vu Z, Vasil&rsquo;ev AN. [Risk of infection with hepatitis B and C viruses of medical workers, patients in the hemodialysis ward, and vaccine prophylaxis of hepatitis B infection in these populations]. Vopr Virusol 1994;39:226-229."},{"key":"ref51","unstructured":"European Best Practice Guidelines. Prevention and management of HBV, HCV and HIV in HD patients. Nephrol Dial Transpl 2002;17:72-87."},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02877.x"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.5414\/CNP68228"},{"key":"ref54","unstructured":"Centers for Disease Control and Prevention (CDC). Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials. MMWR Morb Mortal Wkly Rep 2008;57:875-876."},{"key":"ref55","unstructured":"Roznovsk&yacute; L, Tvrd&iacute;k J, Kabieszov&aacute; L, Petrousov&aacute; L, Ors&aacute;gov&aacute; I, Hoz&aacute;kov&aacute; L, Lochman I, Kloudov&aacute; A, Valkovsk&yacute; I, Letocha P. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up]. Vnitr Lek 2011;57:808-814."},{"key":"ref56","unstructured":"Sengar DP, McLeish WA, Sutherland M, Couture RA, Rashid A. Hepatitis B antigen (HBAg) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAg. Can Med Assoc J 1975;112:968, 971."},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Sengar DP, Rashid A, Jindal SL, Christie CJ. HLA antigens in HBsAg infection. Vox Sang 1979;36:353-355.","DOI":"10.1111\/j.1423-0410.1979.tb04510.x"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(90)90226-H"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00062.x"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-75"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1159\/000329932"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02264.x"},{"key":"ref63","unstructured":"Shatat HZ, Kotkat AM, Farghaly AG. Immune response to hepatitis B vaccine in haemodialysis patients. J Egypt Public Health Assoc 2000;75:257-275."},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408233110803"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2011.559300"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027613"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1159\/000168977"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00180.x"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Alavian SM, Tabatabaei SV. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature. Vaccine 2010;28:3773-3777.","DOI":"10.1016\/j.vaccine.2010.03.038"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.086"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2003.01716.x"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Marangi AL, Giordano R, Montanaro A, De Padova F, Schiavone MG, Dongiovanni G, Basile C. Hepatitis B virus infection in chronic uremia: long-term follow-up of a two-step integrated protocol of vaccination. Am J Kidney Dis 1994;23:537-542.","DOI":"10.1016\/S0272-6386(12)80375-1"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.6.1204"},{"key":"ref74","unstructured":"Chanchairujira T, Chantaphakul N, Thanwandee T, Ong-Ajyooth L. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients. J Med Assoc Thai 2006;89 Suppl 2:S33-S40."},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Barraclough KA, Wiggins KJ, Hawley CM, van Eps CL, Mudge DW, Johnson DW, Whitby M, Carpenter S, Playford EG. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis 2009;54:95-103.","DOI":"10.1053\/j.ajkd.2009.03.010"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03002.x"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01249.x"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1086\/377135"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11913-1"},{"key":"ref80","unstructured":"Puoti M, Airoldi M, Bruno R, Zanini B, Spinetti A, Pezzoli C, Patroni A, Castelli F, Sacchi P, Filice G. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev 2002;4:27-35."},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.1.74"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009;58:1-207; quiz CE1-4.","DOI":"10.1037\/e537722009-001"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1080\/00365540701522975"},{"key":"ref84","unstructured":"Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM, Janssen RS, Ward JW. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006;55:1-33; quiz CE1-4."},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00535.x"},{"key":"ref86","unstructured":"European AIDS Clinical Society. Guidelines Version 6 - October 2011. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/europeanaidsclinicalsociety.org\/images\/stories\/EACSPdf\/EACSGuidelines-v6.0-English.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/europeanaidsclinicalsociety.org\/images\/stories\/EACSPdf\/EACSGuidelines-v6.0-English.pdf<\/ext-link>."},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00637.x"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1086\/420740"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00389-8"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.3.454"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1086\/433180"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2007.007197"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.05.1226"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq137"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.10.040"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.11.057"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.06.079"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.028"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1038\/nri2524"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-285528"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-013383"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.03.022"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.04.042"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838667"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1086\/653707"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"Zhao DM, Thornton AM, DiPaolo RJ, Shevach EM. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 2006;107:3925-3932.","DOI":"10.1182\/blood-2005-11-4502"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Whitaker JA, Rouphael NG, Edupuganti S, Lai L, Mulligan MJ. Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. Lancet Infect Dis 2012;12:966-976.","DOI":"10.1016\/S1473-3099(12)70243-8"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.351"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.01.114"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00674.x"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200104000-00010"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200104000-00009"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1996-0"},{"key":"ref114","unstructured":"Leonardi S, Longo R, Cotugno M, Tardino L, Spina M, Lionetti E, La Rosa M. [Vaccination and celiac disease: results of a retrospective study]. Minerva Pediatr 2011;63:363-367."},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07701.x"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2446"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.060"},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"Gasbarrini G, Miele L, Malandrino N, Grieco A, Addolorato G, Gasbarrini A, Cammarota G, Bonvicini F. Celiac disease in the 21st century: issues of under- and over-diagnosis. Int J Immunopathol Pharmacol 2009;22:1-7.","DOI":"10.1177\/039463200902200101"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.075119"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32832e9d41"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.099"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.195"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i40.5729"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1007\/BF00275749"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.1995.tb03404.x"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.4161\/hv.19107"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-3-356"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2000.4933"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.531"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1136\/adc.78.1.54"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04589.x"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010502"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607243150401"},{"key":"ref134","doi-asserted-by":"crossref","unstructured":"Hayashi J, Noguchi A, Nakashima K, Morofuji M, Kashiwagi S. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients. Eur J Epidemiol 1991;7:649-653.","DOI":"10.1007\/BF00218676"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(88)90016-3"},{"key":"ref136","doi-asserted-by":"crossref","unstructured":"Van Damme P, Vranckx R, Meheus A. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down&rsquo;s syndrome. Vaccine 1990;8 Suppl:S53-S55; discussion S60-S62.","DOI":"10.1016\/0264-410X(90)90236-F"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.3109\/00365549309169664"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2013.07.003"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.150.6.1195"},{"key":"ref140","doi-asserted-by":"crossref","unstructured":"Nagafuchi S, Kashiwagi S, Okada K, Anzai K, Nakamura M, Nishimura Y, Sasazuki T, Niho Y. Reversal of nonresponders and postexposure prophylaxis by intradermal hepatitis B vaccination in Japanese medical personnel. JAMA 1991;265:2679-2683.","DOI":"10.1001\/jama.1991.03460200059035"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1086\/502012"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.4.5687"},{"key":"ref143","doi-asserted-by":"crossref","unstructured":"Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev 2005;CD000100.","DOI":"10.1002\/14651858.CD000100.pub3"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03720030025027"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1136\/jech.46.6.587"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21035"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)07239-6"},{"key":"ref148","doi-asserted-by":"crossref","unstructured":"Leonardi S, Leggio T, Barone P, Sciacca A, Musumeci S. Immune response of subjects at high risk of hepatitis B to a new genetically engineered hepatitis B vaccine administered in low doses by the intradermal route. Acta Paediatr Jpn 1990;32:361-364.","DOI":"10.1111\/j.1442-200X.1990.tb00844.x"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i30\/10383.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T22:38:17Z","timestamp":1565735897000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i30\/10383.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":148,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v20.i30.10383","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}